Pembrolizumab plus chemotherapy for advanced and recurrent cervical cancer: final analysis according to bevacizumab use in the randomized KEYNOTE-826 study

Authors: D. Lorusso, Nicoletta Colombo, Coraline Dubot, M.V. Cáceres, Kazuki Hasegawa, Ronnie Shapira‐Frommer, Pamela Salman, Eduardo Yáñez, Mahmut Gümüş, Mivael Olivera, Vanessa Samouëlian, Vincent Castonguay, A. Arkhipov, Ka Wan Li, S. Toker, C. Tekin, Krishnansu S. Tewari, B.J. Monk - Annals of Oncology 2024 cited by 49